mhurhangee/ep-ind-claims huggingface dataset:
An apparatus comprising: a sensing circuit configured to generate a sensed physiological signal, wherein the physiological signal includes physiological information of a subject; a detection circuit electrically coupled to the sensing circuit and configured to detect a physiological condition of a subject using the physiological signal; and a control circuit configured to store sampled values of a segment of the physiological signal in temporary memory storage in response to an indication of onset of at least one of syncope or atrial fibrillation from the detection circuit; and to store the sampled values in non-temporary storage in response to receiving an indication of confirmation of the at least one of syncope or atrial fibrillation. a sensing circuit configured to generate a sensed physiological signal, wherein the physiological signal includes physiological information of a subject; a detection circuit electrically coupled to the sensing circuit and configured to detect a physiological condition of a subject using the physiological signal; and a control circuit configured to store sampled values of a segment of the physiological signal in temporary memory storage in response to an indication of onset of at least one of syncope or atrial fibrillation from the detection circuit; and to store the sampled values in non-temporary storage in response to receiving an indication of confirmation of the at least one of syncope or atrial fibrillation.
A method of screening for the presence of cancer in a subject, comprising (a) contacting a biological sample from a subject with a gene expression detection assay, wherein said gene expression detection assay comprises a gene expression informative reagent for identification of the level of expression of a non-coding RNA described by SEQ ID NO: 2304; (b) detecting the level of expression of said non-coding RNA in said sample using an in vitro assay; and (c) diagnosing cancer in said subject when an increased level of expression of said non-coding RNA in said sample relative to the level in normal cells is detected. (a) contacting a biological sample from a subject with a gene expression detection assay, wherein said gene expression detection assay comprises a gene expression informative reagent for identification of the level of expression of a non-coding RNA described by SEQ ID NO: 2304; (b) detecting the level of expression of said non-coding RNA in said sample using an in vitro assay; and (c) diagnosing cancer in said subject when an increased level of expression of said non-coding RNA in said sample relative to the level in normal cells is detected.
Method for the fabrication of a solid electrolyte thin film for a battery, comprising the steps of: a) procuring an optionally conductive substrate film, optionally previously coated witch an anode or cathode film, b) depositing an electrolyte thin film by electrophoresis, from a suspension of particles of electrolyte material, on said substrate and/or said previously formed anode or cathode film, c) drying the film thus obtained; d) consolidating the electrolyte thin film obtained at the previous step, by mechanical compression and/or heat treatment, characterized in that the thickness of the deposited electrolyte film is less than 5 μm and in that the average size D 50 of the particles of solid electrolyte material is less 100 nm and more preferably less than or equal to 30 nm. a) procuring an optionally conductive substrate film, optionally previously coated witch an anode or cathode film, b) depositing an electrolyte thin film by electrophoresis, from a suspension of particles of electrolyte material, on said substrate and/or said previously formed anode or cathode film, c) drying the film thus obtained; d) consolidating the electrolyte thin film obtained at the previous step, by mechanical compression and/or heat treatment,
A four stroke internal combustion engine comprising at least one cylinder arrangement, an exhaust conduit, and a turbine comprising a turbine wheel, the turbine having a turbine wheel inlet area, A TIN, wherein the at least one cylinder arrangement forms a combustion chamber and comprises a piston arranged to reciprocate in a cylinder bore and an exhaust port arrangement, the exhaust port arrangement being configured to open and close an exhaust flow area, A CYL, during an exhaust sequence of the piston reciprocation, wherein the cylinder arrangement has a maximum volume, V MAX, between a bottom dead centre, BDC, of the piston and an upper inner delimiting surface of the combustion chamber, wherein the exhaust conduit extends between the exhaust flow area, A CYL, and the turbine wheel inlet area, A TIN, and has an exhaust conduit volume, V EXH, wherein the exhaust port arrangement comprises electronically and/or hydraulically operated exhaust poppet valves, characterized in that, the exhaust conduit volume, V EXH, is ≤ 0.5 times the maximum volume, V MAX, and wherein the turbine has a normalised effective flow area, γ, defined as γ = A TURB /V MAX, wherein γ > 0.22 m -1, wherein A TURB = (A TIN /A TOT) * m' RED * (R/(κ(2/(κ +1) X))) 1/2, wherein X = (κ+1)/(κ-1), wherein A TOT is a total inlet area of the turbine, and wherein A TURB is obtained at a reduced mass flow, m' RED, of the turbine at 2.5 - 3.5 pressure ratio between an inlet side and an outlet side of the turbine and at a tip speed of 450 m/s of the turbine wheel, and wherein the exhaust port arrangement is configured to expose the exhaust flow area, A CYL, at a size of at least 0.22 times the maximum volume, V MAX, when the piston is at the bottom dead centre, BDC, wherein a momentary cylinder volume, V, of the cylinder arrangement is defined by a momentary position of the piston in the cylinder bore during its reciprocation, wherein A CYL expresses the exhaust flow area, A CYL, as a function of the momentary cylinder volume, V, during a power stroke of the piston, wherein an exhaust flow area coefficient, δ, is defined as δ = A CYL /(0.22*V MAX), A CYL being expressed in m 2 and V MAX being expressed in m 3, wherein the exhaust port arrangement has an opening speed coefficient, β, defined as β = (V(δ=1)-V(δ=0.1))/V MAX, and wherein the exhaust flow area, A CYL, has the opening speed coefficient β < 0.06.
A water purification method, comprising: dispersing a water-purifying agent in water to obtain a dispersion liquid of a powder of Corchorus olitorius and a polymeric flocculant, and feeding the dispersion liquid to wastewater including an inorganic unnecessary substance to remove the inorganic unnecessary substance in the wastewater, wherein the wastewater is wastewater including the inorganic unnecessary substance that contains at least any one of nickel, fluorine, iron, copper, zinc, chromium, arsenic, cadmium, tin, and lead, and further comprising the step of subjecting at least any one of inorganic ions selected from the group consisting of a nickel ion, a fluorine ion, an iron ion, a copper ion, a zinc ion, a chromium ion, an arsenic ion, a cadmium ion, a tin ion, and a lead ion contained in the inorganic unnecessary substance to an insolubilizing treatment, wherein the step of feeding the dispersion liquid to the wastewater is done after the step of subjecting the at least any one of inorganic ions to the insolubilizing treatment; wherein the water-purifying agent comprises a granulated product that is a mixture of a powder of Corchorus olitorius and a polymeric flocculant, wherein the particle diameter of the granulated product is within a range of from 250 micrometers through 850 micrometers. dispersing a water-purifying agent in water to obtain a dispersion liquid of a powder of Corchorus olitorius and a polymeric flocculant, and feeding the dispersion liquid to wastewater including an inorganic unnecessary substance to remove the inorganic unnecessary substance in the wastewater, wherein the wastewater is wastewater including the inorganic unnecessary substance that contains at least any one of nickel, fluorine, iron, copper, zinc, chromium, arsenic, cadmium, tin, and lead, and further comprising the step of subjecting at least any one of inorganic ions selected from the group consisting of a nickel ion, a fluorine ion, an iron ion, a copper ion, a zinc ion, a chromium ion, an arsenic ion, a cadmium ion, a tin ion, and a lead ion contained in the inorganic unnecessary substance to an insolubilizing treatment, wherein the step of feeding the dispersion liquid to the wastewater is done after the step of subjecting the at least any one of inorganic ions to the insolubilizing treatment; wherein the water-purifying agent comprises a granulated product that is a mixture of a powder of Corchorus olitorius and a polymeric flocculant, wherein the particle diameter of the granulated product is within a range of from 250 micrometers through 850 micrometers.
A method for redirecting roaming network traffic in an LTE, Long Term Evolution, network, the method being performed by an NTR, Network Traffic Redirection Module and comprising: observing a registration process of a subscriber in an LTE Radio Access Technology, RAT, network within a visited network by intercepting registration messages between a network entity of the subscriber's home network and a network entity of the visited network; and, in response to said observation; sending one or more messages to the network entity of the visited network to induce a re-registration attempt by the subscriber to a legacy RAT network within the visited network; and responsive to the NTR observing an induced re-registration attempt by the subscriber which attempts to register to the legacy RAT network, the NTR applying one or more legacy RAT network steering techniques to re-direct the re-registration process of the subscriber to a target LTE visited network. observing a registration process of a subscriber in an LTE Radio Access Technology, RAT, network within a visited network by intercepting registration messages between a network entity of the subscriber's home network and a network entity of the visited network; and, in response to said observation; sending one or more messages to the network entity of the visited network to induce a re-registration attempt by the subscriber to a legacy RAT network within the visited network; and responsive to the NTR observing an induced re-registration attempt by the subscriber which attempts to register to the legacy RAT network, the NTR applying one or more legacy RAT network steering techniques to re-direct the re-registration process of the subscriber to a target LTE visited network.
A UBE3A vector, comprising: a transcription initiation sequence, wherein the transcription initiation sequence is a cytomegalovirus chicken-beta actin hybrid promotor, or a human ubiquitin c promotor; a UBE3A sequence disposed downstream of the transcription initiation sequence, wherein the UBE3A sequence is SEQ ID NO: 6, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 15, a cDNA of SEQ ID NO: 7, a cDNA of SEQ ID NO: 14, or a nucleotide sequence possessing at least 95% sequence identity thereto; a secretion sequence disposed downstream of the transcription initiation sequence, wherein the secretion sequence is SEQ ID NO: 2, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, a cDNA of SEQ ID NO: 3, or a nucleotide sequence possessing at least 80% sequence identity thereto; and a cell uptake sequence disposed downstream of the transcription initiation sequence, wherein the cell uptake sequence is SEQ ID NO: 4, a cDNA of SEQ ID NO: 5, or a nucleotide sequence possessing at least 80% sequence identity thereto wherein a therapeutically effective amount of E6-associated protein (E6-AP) expressed by cells transfected with the UBE3A vector is secreted and taken up by cerebral cells with a deficiency in E6-AP expression. a transcription initiation sequence, wherein the transcription initiation sequence is a cytomegalovirus chicken-beta actin hybrid promotor, or a human ubiquitin c promotor; a UBE3A sequence disposed downstream of the transcription initiation sequence, wherein the UBE3A sequence is SEQ ID NO: 6, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 15, a cDNA of SEQ ID NO: 7, a cDNA of SEQ ID NO: 14, or a nucleotide sequence possessing at least 95% sequence identity thereto; a secretion sequence disposed downstream of the transcription initiation sequence, wherein the secretion sequence is SEQ ID NO: 2, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, a cDNA of SEQ ID NO: 3, or a nucleotide sequence possessing at least 80% sequence identity thereto; and a cell uptake sequence disposed downstream of the transcription initiation sequence, wherein the cell uptake sequence is SEQ ID NO: 4, a cDNA of SEQ ID NO: 5, or a nucleotide sequence possessing at least 80% sequence identity thereto wherein a therapeutically effective amount of E6-associated protein (E6-AP) expressed by cells transfected with the UBE3A vector is secreted and taken up by cerebral cells with a deficiency in E6-AP expression.
A drug delivery device (200, 600), comprising: - a housing having an exterior surface, - a drug-filled cartridge or means for receiving a drug-filled cartridge, the cartridge comprising an outlet and an axially displaceable piston, - drug expelling means comprising: - a drive member adapted to engage and axially move the piston to thereby expel an amount of drug from the cartridge through the outlet, and - an indicator member arranged to move corresponding to an action performed on or by the drug delivery device, - input means (351, 353) adapted to be actuated, directly or indirectly, by movement of the indicator member, - a display (320, 720) adapted to display a time parameter, - a processor (330, 730), and - an energy source (340, 740), wherein: - the processor is adapted to, based on input from the input means, control the display to display a time parameter related to the time the input means was actuated, characterized by further comprising: - a flexible sheet (300, 700) on which is formed or mounted: - the input means (351, 353), - the display (320, 720), - the processor (330, 730), and - the energy source (340, 740), wherein: - the flexible sheet is mounted at least in part to the exterior of the housing. - a housing having an exterior surface, - a drug-filled cartridge or means for receiving a drug-filled cartridge, the cartridge comprising an outlet and an axially displaceable piston, - drug expelling means comprising: - a drive member adapted to engage and axially move the piston to thereby expel an amount of drug from the cartridge through the outlet, and - an indicator member arranged to move corresponding to an action performed on or by the drug delivery device, - a drive member adapted to engage and axially move the piston to thereby expel an amount of drug from the cartridge through the outlet, and - an indicator member arranged to move corresponding to an action performed on or by the drug delivery device, - input means (351, 353) adapted to be actuated, directly or indirectly, by movement of the indicator member, - a display (320, 720) adapted to display a time parameter, - a processor (330, 730), and - an energy source (340, 740), - the processor is adapted to, based on input from the input means, control the display to display a time parameter related to the time the input means was actuated, characterized by further comprising: - a flexible sheet (300, 700) on which is formed or mounted: - the input means (351, 353), - the display (320, 720), - the processor (330, 730), and - the energy source (340, 740), - the input means (351, 353), - the display (320, 720), - the processor (330, 730), and - the energy source (340, 740), - the flexible sheet is mounted at least in part to the exterior of the housing.
An implantable medical device comprising: a. a plurality of circumferentially self-expansible members comprising a plurality of geometrically deformable closed cells, the closed cells being interconnected to form a tubular structure; b. a plurality of bridge members interconnecting adjacent circumferentially self-expansible members, each bridge member linking a first interconnection between two adjacent closed cells in a first circumferentially self-expansible member to a second interconnection between two adjacent closed cells in a second circumferentially self-expansible member, wherein the second interconnection is circumferentially offset and non-adjacent to the first interconnection; and characterized by an orientation of the plurality of bridge members alternating between circumferentially offset closed cells in adjacent pairs of circumferentially self-expansible members. a. a plurality of circumferentially self-expansible members comprising a plurality of geometrically deformable closed cells, the closed cells being interconnected to form a tubular structure; b. a plurality of bridge members interconnecting adjacent circumferentially self-expansible members, each bridge member linking a first interconnection between two adjacent closed cells in a first circumferentially self-expansible member to a second interconnection between two adjacent closed cells in a second circumferentially self-expansible member, wherein the second interconnection is circumferentially offset and non-adjacent to the first interconnection; and
A pixel unit comprising: a thin film transistor, a pixel electrode and a common electrode, the thin film transistor comprising a gate electrode, a gate insulating layer provided on the gate electrode, an active layer provided on the gate insulating layer, a source electrode and a drain electrode which are provided on the active layer, and a passivation layer provided on the source electrode and the drain electrode, wherein the common electrode is provided directly on the passivation layer; and the pixel electrode is provided under the passivation layer and is connected to the drain electrode of the thin film transistor, characterized in that the pixel electrode and the gate electrode are disposed in a same layer, a gate insulating layer is provided between the passivation layer and the pixel electrode, and a connecting electrode in a same layer as the common electrode is connected to the drain electrode of the thin film transistor and the pixel electrode through two via holes (81, 82), respectively.
An Advanced Gaming Visualization System, AGVS, apparatus, characterised by comprising: a monocular unit comprising an eyepiece, a magnification lens, and a fine-focus assembly, wherein the magnification lens and the fine-focus assembly are configured to focus an image rendered on a display of a mobile computing device; a trigger unit for indicating a trigger actuation at the display of the mobile computing device, wherein the trigger unit includes a trigger, a trigger bar, and a grip, and wherein the trigger is mechanically or electronically coupled to the trigger bar, and wherein, when the trigger is actuated, the trigger bar is configured to move to physically touch the display; a mounting component for mounting the mobile computing device in relation to the monocular unit and the trigger unit; and adjustment wheels (110a, 110b) for adjusting the position of the mobile computing device in relation to the monocular unit, the trigger unit, and the mounting component. a monocular unit comprising an eyepiece, a magnification lens, and a fine-focus assembly, wherein the magnification lens and the fine-focus assembly are configured to focus an image rendered on a display of a mobile computing device; a trigger unit for indicating a trigger actuation at the display of the mobile computing device, wherein the trigger unit includes a trigger, a trigger bar, and a grip, and wherein the trigger is mechanically or electronically coupled to the trigger bar, and wherein, when the trigger is actuated, the trigger bar is configured to move to physically touch the display; a mounting component for mounting the mobile computing device in relation to the monocular unit and the trigger unit; and adjustment wheels (110a, 110b) for adjusting the position of the mobile computing device in relation to the monocular unit, the trigger unit, and the mounting component.
An electronic endoscope system (10, 200, 230, 250, 300) comprising: a light source device (16, 17, 201, 231, 251) for applying illumination light to an internal body part, said illumination light including special light in a specific wavelength band and including normal light being white light ranging from a blue wavelength band to a red wavelength band; an electronic endoscope for capturing an endoscopic image of said internal body part irradiated with said illumination light by using an image sensor, said endoscopic image including a special image captured under said special light and including a normal image of said internal body part irradiated with said normal light; an object distance detection means for detecting from said endoscopic image an object distance being a distance between said image sensor and an inspection area of said internal body part; wherein said object distance detection means obtains said object distance from said normal image, a binning processing means for applying a binning process to said special image; and characterized by a binning processing control means for determining a binning number used in said binning process in accordance with said object distance, wherein said binning processing control means is adapted to decrease said binning number with increase in said object distance, and to increase said binning number with decrease in said object distance, in order to adjust resolution of said special image. a light source device (16, 17, 201, 231, 251) for applying illumination light to an internal body part, said illumination light including special light in a specific wavelength band and including normal light being white light ranging from a blue wavelength band to a red wavelength band; an electronic endoscope for capturing an endoscopic image of said internal body part irradiated with said illumination light by using an image sensor, said endoscopic image including a special image captured under said special light and including a normal image of said internal body part irradiated with said normal light; an object distance detection means for detecting from said endoscopic image an object distance being a distance between said image sensor and an inspection area of said internal body part; wherein said object distance detection means obtains said object distance from said normal image, a binning processing means for applying a binning process to said special image; and characterized by a binning processing control means for determining a binning number used in said binning process in accordance with said object distance,